Sigma-Tau Finanziaria (Oncaspar product) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Sigma-Tau Finanziaria (Oncaspar product) General Information

Description

A portfolio of cancer treatment products. The assets is a biologic cancer therapy used as a component of multi-agent chemotherapeutic regimens to treat acute lymphoblastic leukemia (ALL), a rapidly progressing cancer of the white blood cells. It is primarily marketed in the United States, Germany, Poland and certain other countries and is currently under centralized marketing authorization review with the European Medicines Agency.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Acquirer
Primary Office
  • Gaithersburg, MD 20878
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sigma-Tau Finanziaria (Oncaspar product) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sigma-Tau Finanziaria (Oncaspar product)‘s full profile, request access.

Request a free trial

Sigma-Tau Finanziaria (Oncaspar product) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
A portfolio of cancer treatment products. The assets is a biologic cancer therapy used as a component of multi-agent che
Buildings and Property
Gaithersburg, MD
0000 0000-00-00
0000000000 0

0000 000

m ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et d
0000000000000
Redwood City, CA
00 As of 0000
00000
0.00 0000-00-00
000000&0 00000

000 0000

llamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vo
0000000000000
High Point, NC
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sigma-Tau Finanziaria (Oncaspar product) Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ARMO BioSciences Formerly VC-backed Redwood City, CA 00 00000 000000&0 00000
000 000000000000 Formerly PE-Backed High Point, NC 00 00000 00000000 00000
0000000 Venture Capital-Backed Cambridge, MA 000 00000000000 000
000 000000000000 Formerly VC-backed Epalinges, Switzerland 000 00.000 00000000 00.000
0000000000 0000000 Formerly VC-backed Novato, CA 000 00000 000000000 00000
You’re viewing 5 of 12 competitors. Get the full list »

Sigma-Tau Finanziaria (Oncaspar product) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sigma-Tau Finanziaria (Oncaspar product)‘s full profile, request access.

Request a free trial